Fundraising FoxImvivabio
2 known investors
Find your way into Imvivabio
Sign up to see every warm intro you have to Imvivabio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Imvivabio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
Founders & leadership
LH
Lu HanChief Executive Officer
JR
Jiangtao RenChief Scientific Officer
YN
Yajin NiChief Technology Officer
Investors · 2
Frequently asked questions
- What does Imvivabio do?
- A clinical-stage biotechnology company developing allogeneic CAR-T cell therapies for oncology and autoimmune diseases, targeting off-the-shelf and scalable treatments to improve patient access.
- Who are Imvivabio's investors?
- Imvivabio's investors include Decheng Capital, 7G BioVentures.